Ascelia Pharma AB is a startup based in Sweden, most recent round Series-c-plus.
Based in Sweden, Ascelia Pharma AB is a startup. Its most recent tracked round is Series-c-plus.
Ascelia Pharma AB is a biopharmaceutical company focused on developing and commercializing novel drugs for rare cancer conditions, with clinical-stage candidates Orviglance® and Oncoral.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.